Demonstration of the need for cardiovascular and pulmonary normative data for cancer survivors

International Journal of Sports Medicine

Volumn 35, Issue 13, 2014, Pages 1134-1137

  Schneider, C M ^a   Repka, C P ^a   Brown, J M ^a   Lalonde, T L ^a   Dallow, K T ^b   Barlow, C E ^c   Hayward, R ^a  

^a UNIVERSITY OF NORTHERN COLORADO   (United States)

^b North Colorado Medical Center   (United States)

^c Research Department Cooper Institute   (United Kingdom)

Author keywords

cancer rehabilitation; cancer treatment side effects; exercise; population specific normative values

Indexed keywords

ADULT; AGED; CARDIOVASCULAR FUNCTION; FEMALE; FITNESS; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MIDDLE AGED; NEOPLASM; OXYGEN CONSUMPTION; REFERENCE VALUE; RESPIRATORY FUNCTION; SURVIVOR; VERY ELDERLY; VITAL CAPACITY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OXYGEN CONSUMPTION; PHYSICAL FITNESS; REFERENCE VALUES; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SURVIVORS; VITAL CAPACITY; YOUNG ADULT;

EID: 84939889186     PISSN: 01724622     EISSN: 14393964     Source Type: Journal    
DOI: 10.1055/s-0034-1375691     Document Type: Article

References (23)

1. Carver J. R., Shapiro C. L., Ng A., Jacobs L., Schwartz C., Virgo K. S., Hagerty K. L., Somerfield M. R., Vaughn D. J. ASCO Cancer Survivorship Expert Panel American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol: 2007; 25 3991 4008
2. Centers for Disease Control and Prevention Adult participation in aerobic and muscle-strengthening physical activities - United States, 2011. MMWR Morb Mortal Wkly Rep: 2013; 62 326 330
3. Chandran K., Aggarwal D., Migrino R. Q., Joseph J., McAllister D., Konorev E. A., Antholine W. E., Zielonka J., Srinivasan S., Avadhani N. G., Kalyanaraman B. Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. Biophys J: 2009; 96 1388 1398
4. Cunningham A. J., Lockwood G. A., Cunningham J. A. A relationship between perceived self-efficacy and quality of life in cancer patients. Patient Ednc Couns: 1991; 17 71 78
5. th ed. Philadephia Lippincott Williams & Wilkins: 2005
6. Dimeo F., Fetscher S., Lange W., Mertelsmann R., Keul J. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood: 1997; 90 3390 3394
7. Ewer M. S., Swain S. M., Cardinale D., Fadol A., Suter T. M. Cardiac dysfunction after cancer treatment. Texas Heart Inst J: 2011; 38 248 252
8. Harriss D. J., Atkinson G. Ethical standards in sports and exercise science research: 2014 update. Int J Sports Med: 2013; 34 1025 1028
9. Hayward R., Hydock D. S. Doxorubicin cardiotoxicity in the rat: an in vivo characterization. J Am Assoc Lab Anim Sci: 2007; 46 20 32
10. Hydock D. S., Lien C. Y., Hayward R. Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model. J Cardiovasc Pharmacol Ther: 2009; 14 59 67
11. Jones L. W., Eves N. D., Mackey J. R., Peddle C. J., Haykowsky M., Joy A. A., Courneya K. S., Tankel K., Spratlin J., Reiman T. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung cancer: 2007; 55 225 232
12. Lind P. A., Rosfors S., Wennberg B., Glas U., Bevergård S., Fornander T. Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother Oncol: 1998; 49 245 254
13. Makker V., Spriggs D. Principles of Chemotherapy. In: Stubblefield M. D., O'Dell M. W. eds. Cancer Rehabilitation: Principles and Practice. New York Demos Medical Publishing: 2009; 23 52
14. Schneider C. M., Dennehy C. A., Carter S. D. Exercise and Cancer Recovery. Champaign Human Kinetics: 2003
15. Schneider C. M., Hsieh C. C., Sprod L. K., Carter S. D., Hayward R. Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training. Ann Oncol: 2007; 18 1957 1962
16. Simunek T., Sterba M., Popelova O., Adamcova M., Hrdina R., Gersl V. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep: PR: 2009; 61 154 171
17. Smets E. M., Garssen B., Schuster-Uitterhoeve A. L., de Haes J. C. Fatigue in cancer patients. Br J Cancer: 1993; 68 220 224
18. Starkweather A. Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment. Nurs Res Pract: 2010; 2010 281531
19. Theuws J. C., Muller S. H., Seppenwoolde Y., Kwa S. L., Boersma L. J., Hart G. A., Baas P., Lebesque J. V. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study. J Clin Oncol: 1999; 17 3091 3100
20. th ed Baltimore, MD Lippincott Williams & Wilkins: 2010
21. Thorsen L., Nystad W., Stigum H., Hjermstad M., Oldervoll L., Martinsen E. W., Hornslien K., Stromme S. B., Dahl A. A., Fosså S. D. Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapy. The J Sports Med Phys Fitness: 2006; 46 122 127
22. Wampler M. A., Topp K. S., Miaskowski C., Byl N. N., Rugo H. S., Hamel K. Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy. Arch Phys Med Rehabil: 2007; 88 1002 1008
23. Wauters I., Vansteenkiste J. Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy. Expert Rev Anticancer Ther: 2012; 12 1383 1390